95332-26-6

Basic information

• Product Name: Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-
• CAS NO: 95332-26-6
• Molecular Formula: C9H10O4
• Molecular Weight: 182.176
• Mol File: 95332-26-6.mol
• Article Data: 27

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-(95332-26-6)
• EPA Substance Registry System: Benzaldehyde, 2-hydroxy-4-(methoxymethoxy)-(95332-26-6)

Safety Data

• Hazardous Substances Data: 95332-26-6(Hazardous Substances Data)

Upstream product

• 109-87-5 Dimethoxymethane 
• 95-01-2 2,4-Dihydroxybenzaldehyde 
• 13057-17-5 bromethyl methyl ether 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 441356-34-9 2-benzyloxy-4-methoxymethyloxybenzaldehyde 
• 216443-00-4 2-Formyl-5-methoxymethoxyphenyl trifluoromethanesulphonate 
• 441356-74-7 (E)-ethyl 3-[2-(benzyloxy)-4-(methoxymethoxy)phenyl]acrylate 
• 433331-79-4 4'-Ethyl-2-hydroxy-4-(methoxymethyloxy)diphenylmethanol 
• 106737-92-2 2-benzoyloxy-4-hydroxybenzaldehyde 
• 21144-18-3 3-(4-hydroxy-2-methoxyphenyl)-propanoic acid 
• 243449-22-1 2-benzoyloxy-4-(methoxymethoxy)benzaldehyde 
• 178628-84-7 2-Hydroxy-5-iodo-4-methoxymethoxy-benzaldehyde 
• 888739-99-9 4-(methoxymethoxy)-2-{[5-(trifluoromethyl)pyridine-2-yl]oxy}benzaldehyde 
• 142206-82-4 1α-(tert-butyldimethylsilyl)oxy-6β-<4-(tert-butyldimethylsilyl)oxy-2-methoxyphenyl>-2α/β-(2,6-dimethoxyphenoxy)-3,7-dioxabicyclo<3.3.0>octane 
• 142206-82-4 1α-(tert-butyldimethylsilyl)oxy-6α-<4-(tert-butyldimethylsilyl)oxy-2-methoxyphenyl>-2α/β-(2,6-dimethoxyphenoxy)-3,7-dioxabicyclo<3.3.0>octane 
• 142206-85-7 2β-(2,6-dimethoxyphenoxy)-1α-hydroxy-6α-<2-methoxy-4-(3,4-methylenedioxybenzyloxy)phenyl>-3,7-dioxabicyclo<3.3.0>octane 
• 142206-85-7 2β-(2,6-dimethoxyphenoxy)-1α-hydroxy-6β-<2-methoxy-4-(3,4-methylenedioxybenzyloxy)phenyl>-3,7-dioxabicyclo<3.3.0>octane 

Relevant articles and documents

N-CONTAINING CHROMEN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The present invention provides the compounds having the general formula: (I) wherein R1 to R8, and X are as described herein, compositions including the compounds and methods of using the compounds.

STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS

The present invention provides stable pharmaceutical compositions of pegylated carfilzomib compounds, methods for preparing the compositions, and uses of the compositions for treating cancer, including hematologic malignancies such as multiple myeloma. Th

PEGYLATED CARFILZOMIB COMPOUNDS

The present invention provides polymeric pegylated carfilzomib compounds, and pharmaceutically acceptable salts thereof, of Formula I wherein R1, R2, linker, PEG, n and o are as defined herein. The invention also provides methods of